News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
171 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25385)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Business
Sales of Olainfarm in September Increase by 17%
Preliminary consolidated results of AS Olainfarm for September 2017 show that sales made during this month reached 9.63 million euros.
October 16, 2017
·
1 min read
Business
Poxel Announces Third Quarter 2017 Financial Update
POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced today its cash position for the third quarter of 2017.
October 16, 2017
·
3 min read
Genetown
Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants
ConforMIS has obtained additional positive clinical data regarding the performance of its customized partial knee replacement implants.
October 16, 2017
·
5 min read
Drug Development
Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer and for KO-539 in AML at Upcoming AACR-NCI-EORTC International Conference
A late-breaking poster will be presented on Saturday, October 28, 2017.
October 16, 2017
·
4 min read
Drug Development
TG Therapeutics Recaps Clinical Data Presentations at the Upcoming 7th Joint ECTRIMS - ACTRIMS Meeting
TG announced that clinical abstracts featuring data from the Phase II multicenter trial of TG-1101 have been selected for presentation at an upcoming conference.
October 16, 2017
·
6 min read
Business
Cutera Joined By Six Top Physicians for First Medical Advisory Board Meeting
Cutera announces their 2017 Medical Advisory Board members.
October 16, 2017
·
2 min read
Biotech Beach
Children’s Hospital Los Angeles Release: A Liquid Biopsy For Retinoblastoma Developed By Children’s Hospital Los Angeles And Keck Medicine Of USC
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed using a biopsy, retinoblastoma tumors cannot be directly biopsied.
October 16, 2017
·
7 min read
Business
Analogic Appoints Joseph Whitters to Board of Directors
Mr. Whitters joins the Analogic Board with significant experience in healthcare, finance and strategic transactions.
October 16, 2017
·
4 min read
Deals
Teijin Acquires Exclusive Sales Rights To Transcranial Magnetic Stimulation Device In Japan
Teijin Pharma Limited announced today that it has acquired the exclusive sales rights in Japan to the NeuroStar Transcranial Magnetic Stimulation (TMS) for treating depression that does not respond well to normal antidepressant drug-based therapies.
October 16, 2017
·
2 min read
ChemPass And LifeArc Report Positive Results In The Validation of ChemPass Technology In Medicinal Chemistry Programs
ChemPass announced today that they have successfully completed the first phase of their evaluation of ChemPass’ technology for its ability to support LifeArc’s medicinal chemistry programs.
October 16, 2017
·
2 min read
Previous
12 of 18
Next